按首字母搜索

产品名字索引 B

• Butylphthalide (Catalog# : 16122908, Cas# : 6066-49-5)Butylphthalide, also known as 3-n-butylphthalide or NBP, is an antioxidant and one of
• Buthionine Sulphoximine (Catalog# : 16122907, Cas# : 5072-26-4)Buthionine Sulphoximine, also known as NSC-326231, is a gamma-glutamylcysteine synthe
• 布瓦西坦 (Catalog# : 16122906, Cas# : 357336-20-0)Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a ra
• Brigatinib (AP-26113) (Catalog# : 16122905, Cas# : 1197953-54-0)Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual AL
• Brevianamide F (Catalog# : 16122904, Cas# : 38136-70-8)Brevianamide F , also known as cyclo-(L-Trp-L-Pro), belongs to a class of naturally o
• Bohemine (Catalog# : 16122903, Cas# : 189232-42-6)Bohemine is a potent and selective, cell-permeable, cyclin-dependent kinase (CDK) inh
• BMS-687453 (Catalog# : 16122902, Cas# : 1000998-59-3)BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR
• BML-210 (Catalog# : 16122901, Cas# : 537034-17-6)BML-210, also known as CAY10433, is HDAC inhibitor. BML-210 induces growth inhibition
• BIIB021 (Catalog# : 16122868, Cas# : 848695-25-0)BIIB021, also known as CNF2024, is an orally active, purine-scaffold, small-molecule
• BI605906 (Catalog# : 16122867, Cas# : 960293-88-3)BI605906 is a IKK inhibitor. BI605906 inhibits TNF-dependent IB degradation and expre
• Benzbromarone (Catalog# : 16122866, Cas# : 3562-84-3)Benzbromarone is a uricosuric agent and non-competitive inhibitor of xanthine oxidase
• BAY-59-3074 (Catalog# : 16122805, Cas# : 406205-74-1)BAY-59-3074 is a novel cannabinoid CB1/CB2 receptor partial agonist with analgesic pr
• Batimastat (Catalog# : 16122804, Cas# : 130370-60-4)Batimastat (also known as BB-94) is a synthetic matrix metalloproteinase inhibitor th
• BFH772 (Catalog# : 16122778, Cas# : 890128-81-1)BFH772 is a novel potent oral VEGFR2 inhibitor, targeting VEGFR2 kinase with IC50 of
• BI-78D3 (Catalog# : 16122776, Cas# : 883065-90-5)BI-78D3 is a competitive JNK inhibitor with IC50 of 280nM that displays > 100 fold
• BDA-366 (Catalog# : 16122769, Cas# : 1909226-00-1)BDA-366 is a small-molecule Bcl2-BH4 domain antagonist and binds BH4 with high affini
• BI-7273 (Catalog# : 16122742, Cas# : 1883429-21-7)BI-7273 is a potent, selective, and cell-permeable BRD9 BD Inhibitor.
• BI-9564 (Catalog# : 16122740, Cas# : 1883429-22-8)BI-9564 is a selective inhibitor of BRD9 and BRD7 bromodomains with the IC50 of 75 nM
• BAW2881 (NVP-BAW2881) (Catalog# : 16122733, Cas# : 861875-60-7)BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor t
• BMS-983970 (Catalog# : 6111507, Cas# : 1584713-87-0)BMS-983970 is an oral pan-Notch inhibitor for the treatment of cancer.
• BAY-61-3606 (Catalog# : 6111415, Cas# : 648903-57-5)BAY-61-3606 is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM).
• BH3I-1 (Catalog# : 61402, Cas# : 300817-68-9)BH3I-1 is an inhibitor of Bcl-xL with IC 50 of 293.95 M. BH3I-1 is a cell permeable B
• Bax inhibitor peptide V5 (Catalog# : 61401, Cas# : 579492-81-2)Bax inhibitor peptide V5 is a peptide inhibitor of Bax translocation to mitochondria.
• BMS-986020 (Catalog# : 61122, Cas# : 1257213-50-5)BMS-986020 is a lysophosphatidic acid 1 receptor antagonist. BMS-986020 is in Phase 2
• (±)-Bisoprolol hemifumarate (Catalog# : 6111106, Cas# : 104344-23-2)Bisoprolol is a selective type 1 adrenergic receptor blocker.Bisoprolol, on beta 1-ad
• BNC105 (Catalog# : 6111023, Cas# : 945771-74-4)BNC105 is a tubulin polymerization inhibitor with potent antiproliferative and tumor
• 6-bromo-[1,2,4]triazolo[1,5-a]pyridine (Catalog# : 6111002, Cas# : 356560-80-0)6-bromo-[1,2,4]triazolo[1,5-a]pyridine
• Briciclib (Catalog# : 611917, Cas# : 865783-99-9)Briciclib is a small molecule that suppresses cyclin D1 accumulation in cancer cells.
• 3-bromo-1-ethyl-1H-pyrrole-2,5-dione (Catalog# : 1681202, Cas# : 909397-54-2)3-bromo-1-ethyl-1H-pyrrole-2,5-dione,CAS#909397-54-2
• Bexagliflozin(EGT1442) (Catalog# : 1673102, Cas# : 1118567-05-7)EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA(1c)